Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

NCT03428750 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

423

Enrollment

INDUSTRY

Sponsor class

Conditions

Edematous Fibrosclerotic Panniculopathy (Cellulite)

Interventions

BIOLOGICAL: EN3835
BIOLOGICAL: Placebo

Sponsor

Endo Pharmaceuticals